Universal Beteiligungs und Servicegesellschaft mbH Sells 10,527 Shares of Tenet Healthcare Corporation $THC

Universal Beteiligungs und Servicegesellschaft mbH lowered its stake in shares of Tenet Healthcare Corporation (NYSE:THC - Free Report) by 16.2% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 54,527 shares of the company's stock after selling 10,527 shares during the period. Universal Beteiligungs und Servicegesellschaft mbH owned approximately 0.06% of Tenet Healthcare worth $10,863,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors and hedge funds also recently modified their holdings of the stock. Triumph Capital Management acquired a new stake in shares of Tenet Healthcare in the 3rd quarter valued at approximately $25,000. William B. Walkup & Associates Inc. bought a new stake in Tenet Healthcare in the third quarter valued at approximately $32,000. Canada Pension Plan Investment Board acquired a new stake in Tenet Healthcare in the second quarter worth $35,000. Westside Investment Management Inc. boosted its position in shares of Tenet Healthcare by 100.0% during the third quarter. Westside Investment Management Inc. now owns 192 shares of the company's stock worth $39,000 after purchasing an additional 96 shares in the last quarter. Finally, Geneos Wealth Management Inc. grew its holdings in shares of Tenet Healthcare by 50.9% in the 2nd quarter. Geneos Wealth Management Inc. now owns 264 shares of the company's stock valued at $46,000 after buying an additional 89 shares during the period. 95.44% of the stock is owned by institutional investors.

Tenet Healthcare Stock Performance

Shares of Tenet Healthcare stock opened at $180.72 on Monday. The company has a debt-to-equity ratio of 2.18, a current ratio of 1.76 and a quick ratio of 1.68. The firm has a market cap of $15.83 billion, a price-to-earnings ratio of 11.67, a price-to-earnings-growth ratio of 1.36 and a beta of 1.49. Tenet Healthcare Corporation has a one year low of $120.74 and a one year high of $247.21. The stock's 50-day moving average is $211.42 and its 200-day moving average is $204.68.

Tenet Healthcare (NYSE:THC - Get Free Report) last announced its earnings results on Wednesday, February 11th. The company reported $4.70 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $4.08 by $0.62. Tenet Healthcare had a return on equity of 26.33% and a net margin of 6.60%.The business had revenue of $5.53 billion for the quarter, compared to analyst estimates of $5.47 billion. During the same quarter last year, the firm earned $3.44 EPS. Tenet Healthcare's revenue for the quarter was up 8.9% compared to the same quarter last year. Tenet Healthcare has set its FY 2026 guidance at 16.190-18.470 EPS. Equities analysts predict that Tenet Healthcare Corporation will post 17.31 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

Several analysts recently commented on the company. Truist Financial raised their price objective on Tenet Healthcare from $240.00 to $270.00 and gave the stock a "buy" rating in a research note on Tuesday, February 17th. TD Cowen restated a "buy" rating on shares of Tenet Healthcare in a report on Thursday, February 12th. Wells Fargo & Company reiterated an "overweight" rating and set a $265.00 price objective on shares of Tenet Healthcare in a report on Monday, February 16th. UBS Group increased their target price on Tenet Healthcare from $260.00 to $288.00 and gave the stock a "buy" rating in a research note on Thursday, February 12th. Finally, Cantor Fitzgerald reaffirmed an "overweight" rating on shares of Tenet Healthcare in a research note on Wednesday, March 4th. One analyst has rated the stock with a Strong Buy rating, eighteen have assigned a Buy rating and three have issued a Hold rating to the company. According to MarketBeat, the company currently has a consensus rating of "Moderate Buy" and a consensus price target of $250.56.

Insider Transactions at Tenet Healthcare

In other Tenet Healthcare news, EVP Thomas W. Arnst sold 8,000 shares of the business's stock in a transaction dated Monday, March 9th. The shares were sold at an average price of $238.85, for a total transaction of $1,910,800.00. Following the sale, the executive vice president directly owned 12 shares of the company's stock, valued at $2,866.20. The trade was a 99.85% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through this link. Also, insider R. Scott Ramsey sold 8,017 shares of the stock in a transaction dated Monday, March 2nd. The stock was sold at an average price of $232.70, for a total transaction of $1,865,555.90. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 46,517 shares of company stock valued at $10,943,111 over the last 90 days. 0.81% of the stock is owned by corporate insiders.

Tenet Healthcare Profile

Tenet Healthcare Corporation NYSE: THC is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet's operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.

Want to see what other hedge funds are holding THC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Tenet Healthcare Corporation (NYSE:THC - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.